0
2022
Unilateral Biportal Endoscopy Market

Unilateral Biportal Endoscopy Market

by Product Type (Endoscope, Accessory Devices), by Indication (Herniated Discs, Spinal Stenosis, Others), by End User (Hospitals, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A16968
Jun 2022 | Pages: 150
Tables: 142
Charts: 57
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Unilateral Biportal Endoscopy Market Research, 2031

The global unilateral biportal endoscopy market size was $295.31 million in 2021, and is projected to reach $548.43 million by 2031, growing at a CAGR of 6.4% from 2022 to 2031. UBE procedures use endoscopic equipment and supplies to perform unilateral biportal endoscopic spine surgery. They are minimally invasive or non-surgical treatments. Numerous instruments and pieces of equipment, such as procedure-specific scopes, video monitors, imaging tools, anesthetic monitoring tools, light sources, video processors, insufflators, endoscope cabinets, and endoscopy carts or trolleys, are used during endoscopy to ensure a safe and efficient procedure. The primary users of endoscopic equipment include gastroenterologists, gynecologists, nephrologists, neurologists, cardiologists, hepatologists, and surgeons who perform liver transplants. The use of tiny tubes, handheld cameras, and surgical instruments through one or more tiny incisions constitutes the minimally invasive surgical procedure known as an endoscopy. Less pain, a shorter or no hospital stay, or fewer issues with pre- and post-surgery care are the main advantages of UBE endoscopic procedures. As a result, these procedures are less expensive, more efficient, and safer than conventional open operations. The U.S., Canada, UK, Germany, Australia, and a few Middle Eastern countries like the UAE have health insurance companies that cover these procedures further providing unilateral biportal endoscopy market opportunity.

The World Health Organization (WHO) on January 30, 2021 declared COVID-19 as a pandemic and general wellbeing crisis of international concern. COVID-19 has impacted around 210 countries across the globe, owing to the COVID-19 pandemic. State-run administrations across the globe declared inescapable lockdowns as well as social distancing measures to forestall breakdown of the healthcare structure. States have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries and the enhanced response toward these regulations affects the industry. The distribution, production, and store network have been impacted, due to lockdowns across the globe. In addition, the UBE market had a negative impact during the pandemic. All elective procedures were either cancelled or postponed due to the overcrowding of COVID-19 cases in hospitals. Due to reduction in endoscopic procedures across the world and the success rate of this treatment was decreased. Contrary to other surgical procedures, UBE endoscope sales have increased as fewer hospitals and clinics are able to follow and put into practice the exacting COVID-19 guidelines proposed by governing bodies. To reduce the danger of infection, it is advised to employ personal protective equipment, negative pressure suites, and ward isolation. As a result, UBE endoscopic therapy has become expensive overall. The UBE endoscopy market's expansion in 2020 has been constrained by these issues. The market is anticipated to rebound in the upcoming years which will be anticipated by the widespread use of vaccines.

The growth of the unilateral biportal endoscopy market size is driven by need to diagnose and treat a number of serious spinal disorders such as spinal stenosis and herniated discs. Although, UBE doctors and surgeons are in great demand all around the world, with the exception of the UK, where the United Kingdom Central Council for Nursing, Midwifery, and Health has been training nurse UBE for the past ten years, this scarcity of skilled workers in endoscopy is also anticipated throughout Asia-Pacific, Latin America, and Europe. In addition, this scarcity has been seen as a major restraint in the market. To address this issue, a few industry participants, including Olympus, have set up training facilities. The business operates 22 endoscopic training facilities in Asia alone. Such activities will raise knowledge of the most recent developments in endoscopy technology and boost the pool of qualified endoscopic experts.

Furthermore, players in the UBE endoscopy equipment market are encouraged to increase their presence in emerging nations by surge in prevalence of cancer, quick advancements in healthcare infrastructure, rapid expansion of medical tourism, and lax regulatory environments present in these nations. The Middle East, Latin America, and Asia-Pacific are now witnessing a rise in the establishment of UBE endoscopic equipment manufacturing facilities. Important companies like Stryker and KARL STORZ have already established their production and R&D centers in these nations.

Unilateral biportal endoscopy Market, Unilateral biportal endoscopy Market size, Unilateral biportal endoscopy Market share, Unilateral biportal endoscopy Market trends, Unilateral biportal endoscopy Market growth, Unilateral biportal endoscopy Market analysis, Unilateral biportal endoscopy Market forecast, Unilateral biportal endoscopy Market opportunity

The UBE market is segmented on the basis of product type, indication, end user, and region. By product type, the market is bifurcated into endoscope and accessory devices. By indication the market is classified into herniated discs, spinal stenosis and others. The others segment is further segmented into scoliosis, degenerative disc disease. By end user, the market is fragmented into hospitals and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Product Type Segment Review

By product type, the endoscopy segment held largest unilateral biportal endoscopy market share in 2021. The growth of this segment is attributed to technological advancements in endoscopes offering image-guided technology with Artificial Intelligence (AI) and machine learning gaining popularity in the field. The accessory devices segment is expected to show fastest unilateral biportal endoscopy market growth due to increasing use of accessories in various surgical procedures.

Indication Segment Review

By indication, the herniated discs segment was the highest revenue contributor to the market in 2021 and is set to maintain its position through unilateral biportal endoscopy market forecast. The growth of this segment is attributed to increasing number of patients undergoing endoscopic procedures for herniated discs. Moreover, spinal stenosis segment is set to be the fastest growing segment with a CAGR of 7.2% owing to minimized collateral tissue damage and faster recovery.

End User Segment Review

By end user, the hospitals segment was the highest revenue contributor to the market in 2021. The growth of this segment is attributed to the presence of sophisticated surgical equipment in these settings. Additionally, the ambulatory surgical centers segment is anticipated to be the fastest growing segment due to increasing number of healthcare professionally-owned ambulatory care settings to cater to the rising demand for minimally invasive surgeries.

Region Segment Review

Region wise, North America was the highest revenue contributor in 2021. The growth of this segment is attributed to the favorable reimbursement policies for endoscopic procedures in the U.S., high investments by hospitals to purchase new endoscopic equipment, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals. Asia Pacific is set to grow at a highest CAGR due to surge in medical expertise and technological advancement in medical sector.

Key players that operate in the global UBE market are CONMED Corporation, Endovision Co. Ltd., Jiangsu Bonss Medical Technology Co. Ltd., Joimax GmbH, Karl Storz, Maxmorespine, Maxer Endoscopy GmbH, Richard Wolf, Smith & Nephew and Stryker Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the unilateral biportal endoscopy market analysis from 2021 to 2031 to identify the prevailing unilateral biportal endoscopy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the unilateral biportal endoscopy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global unilateral biportal endoscopy market trends, key players, market segments, application areas, and market growth strategies.

Unilateral Biportal Endoscopy Market Report Highlights

Aspects Details
By Product Type
  • Endoscope
  • Accessory Devices
By Indication
  • Herniated Discs
  • Spinal Stenosis
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa,, Saudi Arabia, Rest of LAMEA)
Key Market Players Endovision Co. Ltd., Smith & Nephew, CONMED Corporation, Stryker Corporation, Karl Storz, Maxer Endoscopy GmbH, Richard Wolf, Joimax GmbH, Kinetix Lifesciences, Jiangsu Bonss Medical Technology Co. Ltd.
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Endoscope

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Accessory Devices

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

  • CHAPTER 5: UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Herniated Discs

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Spinal Stenosis

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Others

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

  • CHAPTER 6: UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Hospitals

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 Ambulatory Surgical Centers

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

  • CHAPTER 7: UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY REGION

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 North America

      • 7.2.1 Key trends and opportunities

      • 7.2.2 North America Market size and forecast, by Product Type

      • 7.2.3 North America Market size and forecast, by Indication

      • 7.2.4 North America Market size and forecast, by End User

      • 7.2.5 North America Market size and forecast, by country

        • 7.2.5.1 U.S.
          • 7.2.5.1.1 Market size and forecast, by Product Type
          • 7.2.5.1.2 Market size and forecast, by Indication
          • 7.2.5.1.3 Market size and forecast, by End User
        • 7.2.5.2 Canada
          • 7.2.5.2.1 Market size and forecast, by Product Type
          • 7.2.5.2.2 Market size and forecast, by Indication
          • 7.2.5.2.3 Market size and forecast, by End User
        • 7.2.5.3 Mexico
          • 7.2.5.3.1 Market size and forecast, by Product Type
          • 7.2.5.3.2 Market size and forecast, by Indication
          • 7.2.5.3.3 Market size and forecast, by End User
    • 7.3 Europe

      • 7.3.1 Key trends and opportunities

      • 7.3.2 Europe Market size and forecast, by Product Type

      • 7.3.3 Europe Market size and forecast, by Indication

      • 7.3.4 Europe Market size and forecast, by End User

      • 7.3.5 Europe Market size and forecast, by country

        • 7.3.5.1 Germany
          • 7.3.5.1.1 Market size and forecast, by Product Type
          • 7.3.5.1.2 Market size and forecast, by Indication
          • 7.3.5.1.3 Market size and forecast, by End User
        • 7.3.5.2 France
          • 7.3.5.2.1 Market size and forecast, by Product Type
          • 7.3.5.2.2 Market size and forecast, by Indication
          • 7.3.5.2.3 Market size and forecast, by End User
        • 7.3.5.3 U.K.
          • 7.3.5.3.1 Market size and forecast, by Product Type
          • 7.3.5.3.2 Market size and forecast, by Indication
          • 7.3.5.3.3 Market size and forecast, by End User
        • 7.3.5.4 Italy
          • 7.3.5.4.1 Market size and forecast, by Product Type
          • 7.3.5.4.2 Market size and forecast, by Indication
          • 7.3.5.4.3 Market size and forecast, by End User
        • 7.3.5.5 Spain
          • 7.3.5.5.1 Market size and forecast, by Product Type
          • 7.3.5.5.2 Market size and forecast, by Indication
          • 7.3.5.5.3 Market size and forecast, by End User
        • 7.3.5.6 Rest of Europe
          • 7.3.5.6.1 Market size and forecast, by Product Type
          • 7.3.5.6.2 Market size and forecast, by Indication
          • 7.3.5.6.3 Market size and forecast, by End User
    • 7.4 Asia-Pacific

      • 7.4.1 Key trends and opportunities

      • 7.4.2 Asia-Pacific Market size and forecast, by Product Type

      • 7.4.3 Asia-Pacific Market size and forecast, by Indication

      • 7.4.4 Asia-Pacific Market size and forecast, by End User

      • 7.4.5 Asia-Pacific Market size and forecast, by country

        • 7.4.5.1 Japan
          • 7.4.5.1.1 Market size and forecast, by Product Type
          • 7.4.5.1.2 Market size and forecast, by Indication
          • 7.4.5.1.3 Market size and forecast, by End User
        • 7.4.5.2 China
          • 7.4.5.2.1 Market size and forecast, by Product Type
          • 7.4.5.2.2 Market size and forecast, by Indication
          • 7.4.5.2.3 Market size and forecast, by End User
        • 7.4.5.3 Australia
          • 7.4.5.3.1 Market size and forecast, by Product Type
          • 7.4.5.3.2 Market size and forecast, by Indication
          • 7.4.5.3.3 Market size and forecast, by End User
        • 7.4.5.4 India
          • 7.4.5.4.1 Market size and forecast, by Product Type
          • 7.4.5.4.2 Market size and forecast, by Indication
          • 7.4.5.4.3 Market size and forecast, by End User
        • 7.4.5.5 South Korea
          • 7.4.5.5.1 Market size and forecast, by Product Type
          • 7.4.5.5.2 Market size and forecast, by Indication
          • 7.4.5.5.3 Market size and forecast, by End User
        • 7.4.5.6 Rest of Asia-Pacific
          • 7.4.5.6.1 Market size and forecast, by Product Type
          • 7.4.5.6.2 Market size and forecast, by Indication
          • 7.4.5.6.3 Market size and forecast, by End User
    • 7.5 LAMEA

      • 7.5.1 Key trends and opportunities

      • 7.5.2 LAMEA Market size and forecast, by Product Type

      • 7.5.3 LAMEA Market size and forecast, by Indication

      • 7.5.4 LAMEA Market size and forecast, by End User

      • 7.5.5 LAMEA Market size and forecast, by country

        • 7.5.5.1 Brazil
          • 7.5.5.1.1 Market size and forecast, by Product Type
          • 7.5.5.1.2 Market size and forecast, by Indication
          • 7.5.5.1.3 Market size and forecast, by End User
        • 7.5.5.2 South Africa,
          • 7.5.5.2.1 Market size and forecast, by Product Type
          • 7.5.5.2.2 Market size and forecast, by Indication
          • 7.5.5.2.3 Market size and forecast, by End User
        • 7.5.5.3 Saudi Arabia
          • 7.5.5.3.1 Market size and forecast, by Product Type
          • 7.5.5.3.2 Market size and forecast, by Indication
          • 7.5.5.3.3 Market size and forecast, by End User
        • 7.5.5.4 Rest of LAMEA
          • 7.5.5.4.1 Market size and forecast, by Product Type
          • 7.5.5.4.2 Market size and forecast, by Indication
          • 7.5.5.4.3 Market size and forecast, by End User
  • CHAPTER 8: COMPANY LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Key developments

  • CHAPTER 9: COMPANY PROFILES

    • 9.1 Endovision Co. Ltd.

      • 9.1.1 Company overview

      • 9.1.2 Company snapshot

      • 9.1.3 Operating business segments

      • 9.1.4 Product portfolio

      • 9.1.5 Business performance

      • 9.1.6 Key strategic moves and developments

    • 9.2 Jiangsu Bonss Medical Technology Co. Ltd.

      • 9.2.1 Company overview

      • 9.2.2 Company snapshot

      • 9.2.3 Operating business segments

      • 9.2.4 Product portfolio

      • 9.2.5 Business performance

      • 9.2.6 Key strategic moves and developments

    • 9.3 Joimax GmbH

      • 9.3.1 Company overview

      • 9.3.2 Company snapshot

      • 9.3.3 Operating business segments

      • 9.3.4 Product portfolio

      • 9.3.5 Business performance

      • 9.3.6 Key strategic moves and developments

    • 9.4 Karl Storz

      • 9.4.1 Company overview

      • 9.4.2 Company snapshot

      • 9.4.3 Operating business segments

      • 9.4.4 Product portfolio

      • 9.4.5 Business performance

      • 9.4.6 Key strategic moves and developments

    • 9.5 Kinetix Lifesciences

      • 9.5.1 Company overview

      • 9.5.2 Company snapshot

      • 9.5.3 Operating business segments

      • 9.5.4 Product portfolio

      • 9.5.5 Business performance

      • 9.5.6 Key strategic moves and developments

    • 9.6 Maxer Endoscopy GmbH

      • 9.6.1 Company overview

      • 9.6.2 Company snapshot

      • 9.6.3 Operating business segments

      • 9.6.4 Product portfolio

      • 9.6.5 Business performance

      • 9.6.6 Key strategic moves and developments

    • 9.7 Richard Wolf

      • 9.7.1 Company overview

      • 9.7.2 Company snapshot

      • 9.7.3 Operating business segments

      • 9.7.4 Product portfolio

      • 9.7.5 Business performance

      • 9.7.6 Key strategic moves and developments

    • 9.8 Smith & Nephew

      • 9.8.1 Company overview

      • 9.8.2 Company snapshot

      • 9.8.3 Operating business segments

      • 9.8.4 Product portfolio

      • 9.8.5 Business performance

      • 9.8.6 Key strategic moves and developments

    • 9.9 Stryker Corporation

      • 9.9.1 Company overview

      • 9.9.2 Company snapshot

      • 9.9.3 Operating business segments

      • 9.9.4 Product portfolio

      • 9.9.5 Business performance

      • 9.9.6 Key strategic moves and developments

    • 9.10 CONMED Corporation

      • 9.10.1 Company overview

      • 9.10.2 Company snapshot

      • 9.10.3 Operating business segments

      • 9.10.4 Product portfolio

      • 9.10.5 Business performance

      • 9.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 2. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR ENDOSCOPE, BY REGION, 2021-2031 ($MILLION)
    TABLE 3. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR ENDOSCOPE BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 4. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR ACCESSORY DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 5. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR ACCESSORY DEVICES BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 6. GLOBAL UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 7. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR HERNIATED DISCS, BY REGION, 2021-2031 ($MILLION)
    TABLE 8. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR HERNIATED DISCS BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 9. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR SPINAL STENOSIS, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR SPINAL STENOSIS BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 11. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 13. GLOBAL UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 14. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 15. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR HOSPITALS BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 16. UNILATERAL BIPORTAL ENDOSCOPY MARKET SIZE, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 17. UNILATERAL BIPORTAL ENDOSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 18. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 19. NORTH AMERICA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 20. NORTH AMERICA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 21. NORTH AMERICA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 22. NORTH AMERICA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 23. U.S. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 24. U.S. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 25. U.S. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 26. CANADA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 27. CANADA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 28. CANADA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 29. MEXICO UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 30. MEXICO UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 31. MEXICO UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 32. EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 33. EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 34. EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 35. EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 36. GERMANY UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 37. GERMANY UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 38. GERMANY UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 39. FRANCE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 40. FRANCE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 41. FRANCE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 42. U.K. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 43. U.K. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 44. U.K. UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 45. ITALY UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 46. ITALY UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 47. ITALY UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 48. SPAIN UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 49. SPAIN UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 50. SPAIN UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 51. REST OF EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 52. REST OF EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 53. REST OF EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 54. ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 55. ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 56. ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 57. ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 58. JAPAN UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 59. JAPAN UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 60. JAPAN UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 61. CHINA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 62. CHINA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 63. CHINA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 64. AUSTRALIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 65. AUSTRALIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 66. AUSTRALIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 67. INDIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 68. INDIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 69. INDIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 70. SOUTH KOREA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 71. SOUTH KOREA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 72. SOUTH KOREA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 73. REST OF ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 74. REST OF ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 75. REST OF ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 76. LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 77. LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 78. LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 79. LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 80. BRAZIL UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 81. BRAZIL UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 82. BRAZIL UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 83. SOUTH AFRICA, UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 84. SOUTH AFRICA, UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 85. SOUTH AFRICA, UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 86. SAUDI ARABIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 87. SAUDI ARABIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 88. SAUDI ARABIA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 89. REST OF LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
    TABLE 90. REST OF LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY INDICATION, 2021-2031 ($MILLION)
    TABLE 91. REST OF LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 92.ENDOVISION CO. LTD.: COMPANY SNAPSHOT
    TABLE 93.ENDOVISION CO. LTD.: OPERATING SEGMENTS
    TABLE 94.ENDOVISION CO. LTD.: PRODUCT PORTFOLIO
    TABLE 95.ENDOVISION CO. LTD.: NET SALES,
    TABLE 96.ENDOVISION CO. LTD.: KEY STRATERGIES
    TABLE 97.JIANGSU BONSS MEDICAL TECHNOLOGY CO. LTD.: COMPANY SNAPSHOT
    TABLE 98.JIANGSU BONSS MEDICAL TECHNOLOGY CO. LTD.: OPERATING SEGMENTS
    TABLE 99.JIANGSU BONSS MEDICAL TECHNOLOGY CO. LTD.: PRODUCT PORTFOLIO
    TABLE 100.JIANGSU BONSS MEDICAL TECHNOLOGY CO. LTD.: NET SALES,
    TABLE 101.JIANGSU BONSS MEDICAL TECHNOLOGY CO. LTD.: KEY STRATERGIES
    TABLE 102.JOIMAX GMBH: COMPANY SNAPSHOT
    TABLE 103.JOIMAX GMBH: OPERATING SEGMENTS
    TABLE 104.JOIMAX GMBH: PRODUCT PORTFOLIO
    TABLE 105.JOIMAX GMBH: NET SALES,
    TABLE 106.JOIMAX GMBH: KEY STRATERGIES
    TABLE 107.KARL STORZ: COMPANY SNAPSHOT
    TABLE 108.KARL STORZ: OPERATING SEGMENTS
    TABLE 109.KARL STORZ: PRODUCT PORTFOLIO
    TABLE 110.KARL STORZ: NET SALES,
    TABLE 111.KARL STORZ: KEY STRATERGIES
    TABLE 112.KINETIX LIFESCIENCES: COMPANY SNAPSHOT
    TABLE 113.KINETIX LIFESCIENCES: OPERATING SEGMENTS
    TABLE 114.KINETIX LIFESCIENCES: PRODUCT PORTFOLIO
    TABLE 115.KINETIX LIFESCIENCES: NET SALES,
    TABLE 116.KINETIX LIFESCIENCES: KEY STRATERGIES
    TABLE 117.MAXER ENDOSCOPY GMBH: COMPANY SNAPSHOT
    TABLE 118.MAXER ENDOSCOPY GMBH: OPERATING SEGMENTS
    TABLE 119.MAXER ENDOSCOPY GMBH: PRODUCT PORTFOLIO
    TABLE 120.MAXER ENDOSCOPY GMBH: NET SALES,
    TABLE 121.MAXER ENDOSCOPY GMBH: KEY STRATERGIES
    TABLE 122.RICHARD WOLF: COMPANY SNAPSHOT
    TABLE 123.RICHARD WOLF: OPERATING SEGMENTS
    TABLE 124.RICHARD WOLF: PRODUCT PORTFOLIO
    TABLE 125.RICHARD WOLF: NET SALES,
    TABLE 126.RICHARD WOLF: KEY STRATERGIES
    TABLE 127.SMITH & NEPHEW: COMPANY SNAPSHOT
    TABLE 128.SMITH & NEPHEW: OPERATING SEGMENTS
    TABLE 129.SMITH & NEPHEW: PRODUCT PORTFOLIO
    TABLE 130.SMITH & NEPHEW: NET SALES,
    TABLE 131.SMITH & NEPHEW: KEY STRATERGIES
    TABLE 132.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 133.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 134.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 135.STRYKER CORPORATION: NET SALES,
    TABLE 136.STRYKER CORPORATION: KEY STRATERGIES
    TABLE 137.CONMED CORPORATION: COMPANY SNAPSHOT
    TABLE 138.CONMED CORPORATION: OPERATING SEGMENTS
    TABLE 139.CONMED CORPORATION: PRODUCT PORTFOLIO
    TABLE 140.CONMED CORPORATION: NET SALES,
    TABLE 141.CONMED CORPORATION: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.UNILATERAL BIPORTAL ENDOSCOPY MARKET SEGMENTATION
    FIGURE 2.UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031
    FIGURE 3.UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.UNILATERAL BIPORTAL ENDOSCOPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.UNILATERAL BIPORTAL ENDOSCOPY MARKET,BY PRODUCT TYPE,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPE UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ACCESSORY DEVICES UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 15.UNILATERAL BIPORTAL ENDOSCOPY MARKET,BY INDICATION,2021(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HERNIATED DISCS UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPINAL STENOSIS UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 19.UNILATERAL BIPORTAL ENDOSCOPY MARKET,BY END USER,2021(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031(%)
    FIGURE 22.UNILATERAL BIPORTAL ENDOSCOPY MARKET BY REGION,2021
    FIGURE 23.U.S. UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 24.CANADA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 25.MEXICO UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 26.GERMANY UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 27.FRANCE UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 28.U.K. UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 29.ITALY UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 30.SPAIN UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 31.REST OF EUROPE UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 32.JAPAN UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 33.CHINA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 34.AUSTRALIA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 35.INDIA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 36.SOUTH KOREA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 37.REST OF ASIA-PACIFIC UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 38.BRAZIL UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 39.SOUTH AFRICA, UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 40.SAUDI ARABIA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 41.REST OF LAMEA UNILATERAL BIPORTAL ENDOSCOPY MARKET,2021-2031($MILLION)
    FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 46.COMPETITIVE DASHBOARD
    FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 48.ENDOVISION CO. LTD..: NET SALES ,($MILLION)
    FIGURE 49.JIANGSU BONSS MEDICAL TECHNOLOGY CO. LTD..: NET SALES ,($MILLION)
    FIGURE 50.JOIMAX GMBH.: NET SALES ,($MILLION)
    FIGURE 51.KARL STORZ.: NET SALES ,($MILLION)
    FIGURE 52.KINETIX LIFESCIENCES.: NET SALES ,($MILLION)
    FIGURE 53.MAXER ENDOSCOPY GMBH.: NET SALES ,($MILLION)
    FIGURE 54.RICHARD WOLF.: NET SALES ,($MILLION)
    FIGURE 55.SMITH & NEPHEW.: NET SALES ,($MILLION)
    FIGURE 56.STRYKER CORPORATION.: NET SALES ,($MILLION)
    FIGURE 57.CONMED CORPORATION.: NET SALES ,($MILLION)

 
 

This section provides various opinions of top-level CXOs in the unilateral biportal endoscopy (UBE) industry. In accordance to several interviews conducted, the endoscopy devices market is expected to witness a healthy growth with the rise in demand for minimally invasive surgical procedures. The UBE endoscopy devices market has enhanced interest of the healthcare industry, owing to rise in number of UBE endoscopy procedures and increase in use of these devices in emerging applications to diagnose and treat abnormalities of internal organs and cavities.

In addition, favorable FDA approvals & reimbursement policies pertaining to UBE endoscopy devices in developed economies, surge in patient preference for minimally invasive surgeries, and shorter recovery time & minimal postoperative complications drive the growth of the global UBE endoscopy devices market. However, dearth of trained physicians & endoscopists and infections caused by few endoscopes restrict the growth of the market. On the contrary, unmet medical demands in developing countries are expected to provide remunerative opportunities for market expansion.

According to the perspectives of CXOs of leading companies in the market, enhanced treatment options with high success rate, patient preference toward minimally invasive surgeries, and technological advancements are some major factors that drive the growth of the global UBE endoscopy market. However, stringent regulations, high cost of treatment, and low reimbursement policies hamper the market growth. Presently, endoscopes and accessory devices are the most preferred product type in the UBE endoscopy market.

According to CXOs, increase in awareness regarding technologically advanced devices and rise in knowledge about novel devices are expected to boost the demand for UBE endoscopy devices. Therefore, use of UBE endoscopy devices is expected to increase in the future. In addition, use of UBE endoscopy devices is highest in North America, specially the U.S., owing to increase in incidences of targeted diseases, higher government expenditure on healthcare, followed by Europe, and Asia-Pacific

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The estimated industry size of Unilateral biportal endoscopy market is $295.31 Million in 2021.

A. Spinal decompression surgery is the leading application of Unilateral biportal endoscopy market.

A. The upcoming trends of unilateral biportal endoscopy market are attributed to technological advancements in endoscopes offering image-guided technology with Artificial Intelligence (AI) and machine, learning gaining popularity in the field, treat a number of serious spinal disorders such as spinal stenosis and herniated discs.

A. North America is the largest regional market for Unilateral biportal endoscopy market.

A. CONMED Corporation, Endovision Co. Ltd., Jiangsu Bonss Medical Technology Co. Ltd., Joimax GmbH, Karl Storz, Maxmorespine, Maxer Endoscopy GmbH, Richard Wolf, Smith & Nephew and Stryker Corporation hold the market share in Unilateral biportal endoscopy market.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Unilateral Biportal Endoscopy Market

Start reading instantly.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers